Half-dose ticagrelor versus clopidogrel dual antiplatelet therapy in flow diverter-treated intracranial aneurysms: analysis of platelet reactivity and perioperative safety outcomes.

Acta Neurochir (Wien) · 2026 · PMC12948863 · PMID 41749016

Europe PMC DOI

hedged sentence

0.1600

closest p · 3.2× alpha

0.1600

boldest claim

The sentences

did not reach statistical significanceP = 0.16not close (p > 0.1)

The rate of ischemic complications was numerically higher in the standard-dose clopidogrel group compared to the half-dose ticagrelor group (6.0% vs 2.2%), although this difference did not reach statistical significance ( P = 0.16).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.